In this edition of the Huntington’s Disease Clinical Trials Update, we expand on the ongoing program from VICO Therapeutics and on the recently terminated VIBRANT-HD clinical trials. We also discuss updates from uniQure’s AMT-130 program and PTC therapeutics’ trial of PTC518 and list all currently registered and ongoing clinical trials in Huntington’s disease.
No takes yet. Share an insight, caveat, or question.
Estevez‐Fraga et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: